Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome

Arthritis and Rheumatism

Volumn 50, Issue 6, 2004, Pages 1897-1908

  Hansen, Arne ^a   Gosemann, Mirko ^a   Pruss, Axel ^a   Reiter, Karin ^a   Ruzickova, Sarka ^a,b   Lipsky, Peter E ^c   Dörner, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CHARLES UNIVERSITY   (Czech Republic)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD27 ANTIGEN; CYTIDINE DEAMINASE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN MU CHAIN; MESSENGER RNA; PROTEIN BCL 6;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CASE REPORT; CELL ACTIVITY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; GERMINAL CENTER; HUMAN; MUTATION RATE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RNA TRANSCRIPTION; SJOEGREN SYNDROME;

ADULT; AGED; ANTIGENS, CD19; ANTIGENS, CD27; B-LYMPHOCYTES; BASE SEQUENCE; BIOLOGICAL MARKERS; COMPLEMENTARITY DETERMINING REGIONS; CYTIDINE DEAMINASE; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; EXONUCLEASES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOLOGIC MEMORY; MALE; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; RNA, MESSENGER; SJOGREN'S SYNDROME; TRANSCRIPTION FACTORS;

EID: 2642541037     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20276     Document Type: Article

References (48)

1. Jonsson R, Haga H-J, Gordon T. Sjögren's syndrome. In: Koopman WJ, editor. Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1736-59.
2. Fox RI, Stern M, Michelson P. Update in Sjögren's syndrome. Curr Opin Rheumatol 2000;12:391-8.
3. Xanthou G, Tapinos NI, Polihronis M, Nezis IP, Margaritis LH, Moutsopoulos HM. CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome. Clin Exp Immunol 1999;118:154-63.
4. Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease: the salivary glands of patients with Sjögren's syndrome. J Clin Invest 1998;102:938-46.
5. Bodeutsch C, deWilde PC, Kater L, van den Hoogen FH, Hene RJ, van Houwelingen JC, et al. Monotypic plasma cells in labial salivary glands of patients with Sjögren's syndrome: prognosticator for systemic lymphoproliferative disease. J Clin Pathol 1993;46: 123-8.
6. Bahler DW, Swerdlow SH. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjögren's syndrome) begin as nonmalignant antigen-selected expansion. Blood 1998;91: 1864-72.
7. Ferry JA, Harris NL. Atlas of lymphoid hyperplasia and lymphoma, 1st ed. Philadelphia: WB Saunders; 1997.
8. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
9. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM, and the European Concerted Action on Sjögren's syndrome. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999;42:1765-72.
10. Bohnhorst J, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM. Bm1-bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome. J Immunol 2001;167:3610-8.
11. Bonhorst JO, Thoen JE, Natvig JB, Thompson KM. Significantly depressed percentage of CD27+ (memory) B cells among peripheral blood B cells in patients with primary Sjögren's syndrome. Scand J Immunol 2001;54:421-7.
12. Bonhorst JO, Bjorgan MB, Thoen JE, Jonsson R, Natvig JB, Thompson KM. Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with serum IgG concentration. Clin Immunol 2002;103:79-88.
13. Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, et al. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2002;46:2160-71.
14. Brezinschek HP, Brezinschek RI, Lipsky PE. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 1995;155:190-202.
15. Brezinschek HP, Foster SJ, Brezinschek RI, Dorner T, Domiati-Saad R, Lipsky PE. Analysis of the human VH gene repertoire: differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. J Clin Invest 1997;99:2488-501.
16. Hansen A, Jacobi A, Pruss A, Kaufmann O, Scholze J, Lipsky PE, et al. Comparison of immunoglobulin heavy chain rearrangements between peripheral and glandular B cells in a patient with primary Sjögren's syndrome. Scand J Immunol 2003;57:470-9.
17. Muto T, Muramatsu M, Taniwaki M, Kinoshita K, Honjo T. Isolation, tissue distribution, and chromosomal location of the human activation-induced cytidine deaminase (AID) gene. Genomics 2000;68:85-8.
18. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO, et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the mRNA-editing deaminase family in germinal center B cells. J Biol Chem 1999;274:18470-6.
19. Allman D, Jain A, Dent A, Maile RR, Selvaggi T, Kehry MR, et al. BCL-6 expression during B cell activation. Blood 1996;87:5257-68.
20. Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B, et al. BCL-6 protein is expressed in germinal-center B cells. Blood 1995;86:45-53.
21. Fox RI, Saito I. Criteria for diagnosis of Sjögren's syndrome. Rheum Dis Clin North Am 1994;20:391-407.
22. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
23. Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, Burmester GR, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000;165:5970-9.
24. Yavuz S, Grammer AC, Yavuz AS, Nanki T, Lipsky PE. Comparative characteristics of μ chain and a chain transcripts expressed by individual tonsil plasma cells. Mol Immunol 2001;38:19-34.
25. Ruzickova S, Pruss A, Odendahl M, Wolbart K, Burmester GR, Scholze J, et al. Chronic lymphocytic leukemia preceded by cold agglutinin disease: intraclonal immunoglobulin light chain diversity in VH4-34 expressing single leukemic B cells. Blood 2002;100:3419-22.
26. Kabat EA, Wu TT, Perry HM, Gottesmann KS, Foeller C. Sequences of proteins of immunological interest. 5th ed. Vol. 1. Bethesda (MD): National Institutes of Health; 1991.
27. Yamada M, Wassermann R, Reichard BA, Shane S, Caton AJ, Rovera G. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med 1991;173:395-407.
28. Wang X, Stollar BD. Human immunoglobulin variable region gene analysis by single cell RT-PCR. J Immunol Methods 2000;244:217-25.
29. Wang X, Stollar BD. Immunogobulin VH gene expression in human aging. Clin Immunol 1999;93:132-42.
30. Yamoaka K, Miyasaka N, Sato K, Okuda M, Nishioka K. B cell hyperresponsiveness in Sjögren's syndrome. Autoimmunity 1989; 3:261-9.
31. Geha RS, Rosen FS. The genetic basis of immunoglobulin-class switching. N Engl J Med 1994;330:1008-9.
32. Fear D, McCloskey N, Felsenfeld G, Gould H. A detailed analysis of germline transcription in cytokine stimulated B cells including isolated single cells. Scand J Immunol 2001;54(Suppl 1):5-37.
33. Perrier S, Serre AF, Dubost JJ, Beaujon G, Plazonnet MP, Albuisson E, et al. Increased serum levels of interleukin-10 in Sjögren's syndrome: correlation with increased IgG1. J Rheumatol 2000;20:153-65.
34. Kronfeld U, Halse AK, Jonsson R, Bremell T, Tarkowski A, Carlsten H. Differential immunological aberrations in patients with primary and secondary Sjögren's syndrome. Scand J Immunol 1997;45:698-705.
35. Halse A, Tengner P, Wahren-Herlenius M, Haga H, Jonsson R. Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjögren's syndrome. Scand J Immunol 1999;49:533-8.
36. Hagiwara E, Pando J, Ishigatsubo Y, Klinman DM. Altered frequency of type 1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome. J Rheumatol 1998; 25:89-93.
37. Font J, Garcia-Carrasco M, Ramos-Casals M, Aldea AI, Cervera R, Ingelmo M, et al. The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome. Rheumatology (Oxford) 2002;41:1025-30.
38. Hulkkonen J, Pertovaara M, Antonen J, Lahdenpohja N, Pasternack A, Hurme M. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome. Arthritis Rheum 2001;44:176-9.
39. Amft N, Bowman SJ. Chemokines and cell trafficking in Sjögren's syndrome. Scand J Immunol 2001;54:62-9.
40. Salomonsson S, Larsson P, Tengner P, Mellquist E, Hjelmstrom P, Wahren-Herlenius M. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand J Immunol 2002;55:336-42.
41. Hjelmstrom P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through homing chemokines. J Leukoc Biol 2001;69:331-9.
42. Heimbächer C, Hansen A, Pruss A, Jacobi A, Reiter K, Lipsky PE, et al. Immunoglobulin Vκ light chain gene analysis in patients with Sjögren's syndrome. Arthritis Rheum 2001;44:626-37.
43. Kaschner S, Hansen A, Jacobi A, Reiter K, Monson NL, Odendahl M, et al. Immunoglobulin Vκ light chain gene usage in patients with Sjögren's syndrome. Arthritis Rheum 2001;44:2620-32.
44. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998;188:1679-89.
45. Boursier L, Dunn-Walters DK, Spencer J. Characteristics of IgVH genes used by human intestinal plasma cells from childhood. Immunol 1999;97:558-64.
46. De Wildt RM, Tomlinson IM, van Venrooij WJ, Winter G, Hoet RM. Comparable heavy and light chain pairings in normal and systemic lupus erythematosus IgG+ B cells. Eur J Immunol 2000;30:254-61.
47. Kocks C, Rajewsky K. Stable expression and somatic hypermutation of antibody V regions in B cell developmental pathways. Ann Rev Immunol 1989;7:537-59.
48. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik M, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002;416:603-7.